May 14, 2026 a 04:38 pm
CAH: Analysts Ratings - Cardinal Health, Inc.
Cardinal Health, Inc., a key player in healthcare services and products, operates on an international scale with a focus on two main segments: Pharmaceutical and Medical. The stock has seen varying analyst sentiments recently, but currently stands strong in buy recommendations. This suggests a positive outlook on its potential growth, given the company's strategic positioning in the healthcare industry.
Historical Stock Grades
The following table presents the current distribution of analyst ratings for CAH as of May 1, 2026:
| Rating | Number | Score Bar |
|---|---|---|
| Strong Buy | 3 | |
| Buy | 12 | |
| Hold | 3 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
Over the recent months, there has been a notable consistency in the positive sentiment towards Cardinal Health.
- There has been a gradual increase in 'Strong Buy' ratings, indicating growing confidence in stock performance.
- The 'Buy' ratings have remained consistently strong, maintaining a dominant position among analysts.
- 'Hold' ratings have seen some fluctuations, but overall sentiment leans towards holding rather than selling.
- No significant ratings under 'Sell' or 'Strong Sell', suggesting a low perceived risk among analysts.
Percentage Trends
The changing percentages of the analyst ratings over time reflect strategic adjustments in analyst perspectives.
- From a strong focus on 'Hold' and 'Buy' in mid-2025, the trend has moved towards more confident 'Buy' and 'Strong Buy' recommendations by early 2026.
- The percentage of 'Buy' ratings has risen notably, leading to a shift from cautious optimism towards assertive buying signals.
- Reduction in 'Hold' ratings underscores increased trust in the stock’s potential upside.
- Analysts have displayed a reduced cautionary stance as no sell-side pessimism prevails.
Latest Analyst Recommendations
Recent recommendations reflect a strong positive analyst consensus around maintaining current forecasts.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-05-04 | Neutral | Neutral | JP Morgan |
| 2026-05-01 | Overweight | Overweight | Wells Fargo |
| 2026-05-01 | Buy | Buy | Citigroup |
| 2026-05-01 | Buy | Buy | TD Cowen |
| 2026-04-08 | Outperform | Outperform | Evercore ISI Group |
Analyst Recommendations with Change of Opinion
Changes in opinions often signal evolving outlooks based on new information or performance metrics.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-01-09 | Buy | Neutral | Citigroup |
| 2025-06-03 | Overweight | Equal Weight | Wells Fargo |
| 2025-02-05 | Buy | Hold | Jefferies |
| 2025-01-08 | Buy | Hold | TD Cowen |
| 2025-01-07 | Outperform | In Line | Evercore ISI Group |
Interpretation
Analyzing the trends in analyst ratings suggests Cardinal Health is regarded positively, with minimal signs of uncertainty. Analysts remain predominantly positive barring a few cases of neutrality, showing stabilized confidence in future growth prospects. There is a solid maintaining of positions, indicating trust in the company's performance remains strong. A growth in 'Strong Buy' ratings highlights increased optimism about Cardinal Health's strategic position and ability to capitalize on market opportunities.
Conclusion
Cardinal Health, Inc. represents a promising investment opportunity with strong backing from analysts, as evidenced by a predominant trend in 'Buy' and 'Strong Buy' recommendations. The strategic diversification within their healthcare service sectors enhances potential for stability and growth. Risks appear minimal given the analyst confidence, though market conditions and healthcare regulations should be taken into consideration. Analysts' perspectives showcase trust in steady company performance, aligning with the broader healthcare market's expansion. As Cardinal Health continues to leverage its international presence and comprehensive service offerings, it is positioned to deliver sustained returns as reflected in ongoing positive sentiments from market analysts.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years